How The 21st Century Cures Act Should Support Public Health
We need and can afford both: to raise the bar so that everyone has access to modern healthcare, and to advance treatments through medical science.
Why Patients Support The 21st Century Cures Act
The Cures Act will keep the U.S. at the forefront of medical progress, a draw for scientists and doctors around the world, a source of pride.
The FDA Did The Right Thing By Approving a Novel Drug For A Disabling Disease
The FDA’s decision reflects a thoughtful, not knee-jerk approach to its mission, which is to protect the public from fraudulent and unsafe substances. What’s at issue is how well eteplirsen works. And that it’s too expensive.
A Modern, Adaptive FDA Should Support Patients’ Right To Try New Medications
The agency’s leadership might accomplish what medicine does best: applying science humanely, so that people can get well if it’s possible, and not wait.
Flint’s Lead-Contaminated Water Points To Health Effects Of Ailing Infrastructure
The EPA suggests an action level for lead in water: it should be below 15 parts per billion. Because lead toxicity causes irreversible neurological damage, prevention is crucial.
Patients Shouldn’t Be Used As Hostages, Vulnerable To Sudden Drug Price Increases
Martin Shkreli is not the only bad player in the game of hiking up drug prices.
’60 Minutes’ Is Right To Raise Questions About Lumber Liquidators’ Toxic Floors
Formaldehyde in wood products can cause cancer and other ailments including skin and breathing problems.
Mandatory Reporting Of Breast Density In Screening Mammograms. Why The Controversy?
Women have every right to know if they have dense breasts and if they’re at increased risk for a hidden tumor.
So What About That Acrylamide In Your French Fries?
In 2002, scientists reported that acrylamide forms when seemingly healthy carbohydrate-rich foods like potatoes, other root vegetables and grains are cooked at high temperatures by frying, roasting, broiling, toasting or baking.
Time for Informed Consent: The FDA Considers Risks of Power Morcellators in Fibroid Surgery
Last week, a panel convened by the FDA deliberated over the risks and benefits of using power morcellators in gynecological surgery. In April, the agency issued an alert cautioning providers that the tools could spread malignant cells from an occult malignancy.